Literature DB >> 3552996

Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

N R Payne, Y K Kim, P Ferrieri.   

Abstract

The influence of antibody and complement on the polymorphonuclear leukocytic uptake and killing of type II group B streptococci (GBS) was examined with 11 adult sera and three type II strains possessing the trypsin-resistant and trypsin-sensitive components (II/TR+TS) of the "c" (formerly Ibc) protein or two type II strains lacking both components (II/no c) of the c protein. All tested sera mediated a greater than 1 log10 reduction in colony-forming units (CFUR) of a type II/no c strain, even in the absence of measurable type-specific antibody (less than 1.08 micrograms/ml), but only 5 of 11 mediated a greater than 1 log10 CFUR of any type II/TR/TS strain, even in the presence of moderate levels of type-specific antibody. The classical pathway of complement activation appeared to be more important than the alternative pathway, and even absorbed or immunoglobulin G (IgG)-depleted serum (IgG, 10 mg/dl) mediated a greater than 1 log10 CFUR without magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (magnesium EGTA) chelation. Chelation with magnesium EGTA reduced the CFUR in 4 of 11 test sera and greatly reduced the CFUR in absorbed or IgG-depleted sera for type II/no c strains. Despite variation in the phagocytic killing of two representative strains of type II GBS, both strains were well phagocytized, as measured by radiolabeled bacterial uptake or electron microscopy. This study suggested that poorly killed type II/TR+TS GBS were easily phagocytized but apparently resisted intracellular killing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552996      PMCID: PMC260497          DOI: 10.1128/iai.55.5.1243-1251.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.

Authors:  B Nelson; S Ruddy
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

3.  Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Authors:  M S Edwards; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

4.  The role of complement and antibody in opsonophagocytosis of type II group B streptococci.

Authors:  C J Baker; B J Webb; D L Kasper; M S Edwards
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

5.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Variations in the opsonic requirements of group B streptococcus type III.

Authors:  M J Hastings; C S Easmon
Journal:  Br J Exp Pathol       Date:  1981-10

7.  Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.

Authors:  G W Fischer; K W Hunter; S R Wilson
Journal:  Pediatr Res       Date:  1981-12       Impact factor: 3.756

8.  Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1981-08

9.  Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.

Authors:  P Ferrieri; B Burke; J Nelson
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

10.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  14 in total

1.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Nonimmune binding of human immunoglobulin A to type II group B streptococci.

Authors:  B F Anthony; N F Concepcion; S M Puentes; N R Payne
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 4.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

5.  Molecular species of R-protein antigens produced by clinical isolates of group B streptococci.

Authors:  A E Flores; P Ferrieri
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  bca, beta gene, and gene product divergency in reference and prototype strains of streptococcus agalactiae.

Authors:  J A Maeland; L Bevanger; G Iversen; R V Lyng
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

8.  Molecular analysis of multiple isolates of the major serotypes of group B streptococci.

Authors:  E Fasola; C Livdahl; P Ferrieri
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Protein X of Streptococcus agalactiae induces opsonic antibodies in cows.

Authors:  P Rainard; Y Lautrou; P Sarradin; B Poutrel
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.

Authors:  L C Madoff; J L Michel; E W Gong; A K Rodewald; D L Kasper
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.